New hope for kidney transplant patients: drug may prevent rejection with fewer side effects
Disease control
Completed
This study tested a new medicine called tegoprubart in 127 people who received a kidney transplant. The goal was to see if it works better than the standard drug tacrolimus at preventing the body from rejecting the new kidney. Participants took the study drug and were monitored f…
Phase: PHASE2 • Sponsor: Eledon Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC